NCT00374842View on ClinicalTrials.gov

Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 3, 2006

Primary Completion Date

November 1, 2006

Study Completion Date

November 30, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Fluarix™

GlaxoSmithKline Biologicals' licensed influenza vaccine

BIOLOGICAL

GSK1247446A

Low-dose GlaxoSmithKline Biologicals' GSK1247446A influenza vaccine

Trial Locations (1)

2610

GSK Investigational Site, Wilrijk

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY